Showing results (401-410 of 502) with videos related to
Sort By:
Pageof 51
Head & Neck|March 6, 2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysisAmr Mohamed, Brandon Twardy, Magdi A Zordok, et al.The New England Journal of Medicine|December 14, 2016
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung CancerTony S Mok, Yi-Long Wu, Myung-Ju Ahn, et al.BMJ Oncology|January 31, 2025
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapyRebecca C Obeng, Tahseen H Nasti, Kylee Martens, et al.Cancer|May 3, 2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data BaseKushal B Naik, Yuan Liu, Michael Goodman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Current and Emergent Therapy Options for Advanced Squamous Cell Lung CancerMark A Socinski, Coleman Obasaju, David Gandara, et al.Cancer Medicine|August 16, 2014
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Xingming Deng, et al.Clinical Lung Cancer|February 15, 2021
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400GTaofeek K Owonikoko, Mary W Redman, Lauren A Byers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2024
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA studyS Lu, M-J Ahn, T Reungwetwattana, et al.Healthcare (Amsterdam, Netherlands)|June 27, 2021
Recommendations for strengthening the role of embedded researchers to accelerate implementation in health systems: Findings from a state-of-the-art (SOTA) conference workgroupLaura J Damschroder, Andrew J Knighton, Emily Griese, et al.Proceedings of the National Academy of Sciences of the United States of America|April 28, 2017
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patientsAlice O Kamphorst, Rathi N Pillai, Shu Yang, et al.Pageof 51